CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Contract with Customer, Liability, Noncurrent
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Contract with Customer, Liability, Noncurrent of $48.14 million as of 2026-06-27, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2026-08-05
- 2026-06-27: Contract with Customer, Liability, Noncurrent $48.14M.
- 2026-03-28: Contract with Customer, Liability, Noncurrent $47.06M.
- 2025-12-27: Contract with Customer, Liability, Noncurrent $45.63M.
- 2025-09-27: Contract with Customer, Liability, Noncurrent $42.49M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2026-06-27 | $48.14M 10-Q · filed 2026-08-05 |
| 2026-03-28 | $47.06M 10-Q · filed 2026-05-07 |
| 2025-12-27 | $45.63M 10-Q · filed 2026-08-05 |
| 2025-09-27 | $42.49M 10-Q · filed 2025-11-05 |
| 2025-06-28 | $37.67M 10-Q · filed 2025-08-06 |
| 2025-03-29 | $33.95M 10-Q · filed 2025-05-07 |
| 2024-12-28 | $34.29M 10-Q · filed 2025-11-05 |
| 2024-09-28 | $34.91M 10-Q · filed 2024-11-06 |
| 2024-06-29 | $29.14M 10-Q · filed 2024-08-07 |
| 2024-03-30 | $32.45M 10-Q · filed 2024-05-09 |
| 2023-12-30 | $30.92M 10-Q · filed 2024-11-06 |
| 2022-09-24 | $24.16M 10-Q · filed 2022-11-02 |
| 2022-06-25 | $20.77M 10-Q · filed 2022-08-03 |
| 2022-03-26 | $22.92M 10-Q · filed 2022-05-04 |
| 2021-12-25 | $20.58M 10-Q · filed 2022-11-02 |
| 2021-09-25 | $18.50M 10-Q · filed 2021-11-03 |
| 2021-06-26 | $18.26M 10-Q · filed 2021-08-04 |
| 2021-03-27 | $20.04M 10-Q · filed 2021-05-04 |
| 2020-12-26 | $19.48M 10-K · filed 2022-02-16 |
| 2020-09-26 | $19.12M 10-Q · filed 2020-10-29 |
| 2020-06-27 | $15.79M 10-Q · filed 2020-08-05 |
| 2020-03-28 | $16.08M 10-Q · filed 2020-05-07 |
| 2019-12-28 | $20.98M 10-K · filed 2021-02-17 |
| 2019-09-28 | $25.35M 10-Q · filed 2019-11-06 |
| 2019-06-29 | $27.74M 10-Q · filed 2019-07-31 |
| 2019-03-30 | $28.82M 10-Q · filed 2019-05-07 |
| 2018-12-29 | $34.42M 10-K · filed 2020-02-11 |
| 2018-09-29 | $37.57M 10-Q · filed 2018-11-07 |
| 2017-12-30 | $8.31M 10-K · filed 2019-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |